{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:02:13Z","timestamp":1781848933922,"version":"3.54.5"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T00:00:00Z","timestamp":1516320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s12035-018-0895-1","type":"journal-article","created":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T02:00:36Z","timestamp":1516327236000},"page":"6816-6833","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Combination Therapy with Sulfasalazine and Valproic Acid Promotes Human Glioblastoma Cell Death Through Imbalance of the Intracellular Oxidative Response"],"prefix":"10.1007","volume":"55","author":[{"given":"Carlos Gustavo","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana Assad","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Henrique Medeiros","family":"Geraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Domith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah Christinne Lima e","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"dos Santos Assun\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Jos\u00e9","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Cabral","family":"Portugal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Marcondes","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Ferreira","family":"Rom\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annibal Duarte Pereira","family":"Netto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via Regina Souza","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8636-964X","authenticated-orcid":false,"given":"Marcelo","family":"Cossenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,19]]},"reference":[{"issue":"7","key":"895_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S1474-4422(10)70105-8","volume":"9","author":"M Jansen","year":"2010","unstructured":"Jansen M, Yip S, Louis DN (2010) Molecular pathology in adult gliomas: Diagnostic, prognostic, and predictive markers. Lancet Neurol 9(7):717\u2013726. https:\/\/doi.org\/10.1016\/S1474-4422(10)70105-8","journal-title":"Lancet Neurol"},{"issue":"17","key":"895_CR2","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1001\/jama.2013.280319","volume":"310","author":"A Omuro","year":"2013","unstructured":"Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: A clinical review. JAMA 310(17):1842\u20131850. https:\/\/doi.org\/10.1001\/jama.2013.280319","journal-title":"JAMA"},{"issue":"6","key":"895_CR3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: A summary. Acta Neuropathol 131(6):803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"issue":"4","key":"895_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/neuonc\/nou223","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Gittleman H, Liao P et al (2014) CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2007\u20132011. Neuro-Oncology 16(4):1\u201363. https:\/\/doi.org\/10.1093\/neuonc\/nou223","journal-title":"Neuro-Oncology"},{"issue":"8","key":"895_CR5","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/glia.21143","volume":"59","author":"F Siebzehnrubl","year":"2011","unstructured":"Siebzehnrubl F, Reynolds B, Vescovi A et al (2011) The origins of glioma: E pluribus Unum? Glia 59(8):1135\u20131147. https:\/\/doi.org\/10.1002\/glia.21143","journal-title":"Glia"},{"issue":"30","key":"895_CR6","doi-asserted-by":"publisher","first-page":"4601","DOI":"10.1200\/JCO.2009.27.1932","volume":"28","author":"M Brada","year":"2010","unstructured":"Brada M, Stenning S, Gabe R et al (2010) Temozolomide versus Procarbazine, Lomustine, and vincristine in recurrent high-grade glioma. J Clin Oncol 28(30):4601\u20134608. https:\/\/doi.org\/10.1200\/JCO.2009.27.1932","journal-title":"J Clin Oncol"},{"issue":"8","key":"895_CR7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJMoa1308345","volume":"370","author":"OL Chinot","year":"2014","unstructured":"Chinot OL, Wick W, Mason W et al (2014) Bevacizumab plus radiotherapy\u2013Temozolomide for newly diagnosed glioblastoma. N Engl J Med 370(8):709\u2013722. https:\/\/doi.org\/10.1056\/NEJMoa1308345","journal-title":"N Engl J Med"},{"issue":"23","key":"895_CR8","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1001\/jama.2015.16669","volume":"314","author":"R Stupp","year":"2015","unstructured":"Stupp R, Taillibert S, Kanner AA et al (2015) Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: A randomized clinical trial. JAMA 314(23):2535\u20132543. https:\/\/doi.org\/10.1001\/jama.2015.16669","journal-title":"JAMA"},{"issue":"10","key":"895_CR9","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA et al (2005) Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"issue":"19","key":"895_CR10","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2174\/1568026616666160216155556","volume":"86","author":"H Chen","year":"2016","unstructured":"Chen H, Wu J, Gao Y, Chen H, Zhou J (2016) Scaffold repurposing of old drugs towards new cancer drug discovery. Curr Top Med Chem 86(19):2107\u20132114. https:\/\/doi.org\/10.2174\/1568026616666160216155556","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"895_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2165\/00003088-198510040-00001","volume":"10","author":"U Klotz","year":"1985","unstructured":"Klotz U (1985) Clinical pharmacokinetics of Sulphasalazine, its metabolites and other prodrugs of 5-Aminosalicylic acid. Clin Pharmacokinet 10(4):285\u2013302. https:\/\/doi.org\/10.2165\/00003088-198510040-00001","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"895_CR12","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/sj.leu.2402238","volume":"15","author":"PW Gout","year":"2001","unstructured":"Gout PW, Buckley R, Simms CR, Bruchovsky N (2001) Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: A new action for an old drug. Leukemia 15(10):1633\u20131640. https:\/\/doi.org\/10.1038\/sj.leu.2402238","journal-title":"Leukemia"},{"issue":"31","key":"895_CR13","doi-asserted-by":"publisher","first-page":"7101","DOI":"10.1523\/JNEUROSCI.5258-04.2005","volume":"25","author":"WJ Chung","year":"2005","unstructured":"Chung WJ, Lyons S, Nelson GM et al (2005) Inhibition of cystine uptake disrupts the growth of primary brain tumors. J Neurosci 25(31):7101\u20137110. https:\/\/doi.org\/10.1523\/JNEUROSCI.5258-04.2005","journal-title":"J Neurosci"},{"issue":"3","key":"895_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/jcp.21366","volume":"215","author":"M Lo","year":"2008","unstructured":"Lo M, Wang YZ, Gout PW (2008) The xc- cystine\/glutamate antiporter: A potential target for therapy of cancer and other diseases. J Cell Physiol 215(3):593\u2013602. https:\/\/doi.org\/10.1002\/jcp.21366","journal-title":"J Cell Physiol"},{"issue":"1","key":"895_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1471-4159.2009.06129.x","volume":"110","author":"WJ Chung","year":"2009","unstructured":"Chung WJ, Sontheimer H (2009) Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-kappaB. J Neurochem 110(1):182\u2013193. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06129.x","journal-title":"J Neurochem"},{"issue":"5","key":"895_CR16","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/S0021-9258(17)35926-4","volume":"261","author":"S Bannai","year":"1986","unstructured":"Bannai S (1986) Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J Biol Chem 261(5):2256\u20132263","journal-title":"J Biol Chem"},{"issue":"10","key":"895_CR17","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nm.2453","volume":"17","author":"SC Buckingham","year":"2011","unstructured":"Buckingham SC, Campbell SL, Haas BR, Montana V, Robel S, Ogunrinu T, Sontheimer H (2011) Glutamate release by primary brain tumors induces epileptic activity. Nat Med 17(10):1269\u20131274. https:\/\/doi.org\/10.1038\/nm.2453","journal-title":"Nat Med"},{"issue":"5","key":"895_CR18","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1089\/ars.2011.4391","volume":"18","author":"J Lewerenz","year":"2013","unstructured":"Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, Massie A, Smolders I et al (2013) The Cystine\/glutamate antiporter system x(c)(\u2212) in health and disease: From molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal 18(5):522\u2013555. https:\/\/doi.org\/10.1089\/ars.2011.4391","journal-title":"Antioxid Redox Signal"},{"issue":"49","key":"895_CR19","doi-asserted-by":"publisher","first-page":"5951","DOI":"10.1038\/onc.2015.60","volume":"34","author":"L Sleire","year":"2015","unstructured":"Sleire L, Skeie BS, Netland I et al (2015) Drug repurposing: Sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system xc(\u2212), leading to glutathione depletion. Oncogene 34(49):5951\u20135959. https:\/\/doi.org\/10.1038\/onc.2015.60","journal-title":"Oncogene"},{"issue":"48","key":"895_CR20","doi-asserted-by":"publisher","first-page":"37716","DOI":"10.1074\/jbc.M110.161190","volume":"285","author":"TA Ogunrinu","year":"2010","unstructured":"Ogunrinu TA, Sontheimer H (2010) Hypoxia increases the dependence of glioma cells on glutathione. J Biol Chem 285(48):37716\u201337724. https:\/\/doi.org\/10.1074\/jbc.M110.161190","journal-title":"J Biol Chem"},{"issue":"4","key":"895_CR21","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/0306-4522(92)90278-A","volume":"48","author":"S Kato","year":"1992","unstructured":"Kato S, Negishi K, Mawatari K, Kuo CH (1992) A mechanism for glutamate toxicity in the C6 glioma cells involving inhibition of cystine uptake leading to glutathione depletion. Neuroscience 48(4):903\u2013914. https:\/\/doi.org\/10.1016\/0306-4522(92)90278-A","journal-title":"Neuroscience"},{"issue":"3","key":"895_CR22","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1124\/jpet.109.162248","volume":"332","author":"A Pham","year":"2010","unstructured":"Pham A, Blower PE, Alvarado O et al (2010) Pharmacogenomic approach reveals a role for the xc- Cystine\/glutamate antiporter in growth and Celastrol resistance of glioma cell lines. J Pharmacol Exp Ther 332(3):949\u2013958. https:\/\/doi.org\/10.1124\/jpet.109.162248.produced","journal-title":"J Pharmacol Exp Ther"},{"issue":"16","key":"895_CR23","doi-asserted-by":"publisher","first-page":"5595","DOI":"10.1158\/1078-0432.CCR-03-0392","volume":"10","author":"P Robe","year":"2004","unstructured":"Robe P, Bentires-Alj M, Bonif M et al (2004) In vitro and in vivo activity of the nuclear factor-kB inhibitor sulfasalazine in human glioblastomas. Clin Cancer Res 10(16):5595\u20135603. https:\/\/doi.org\/10.1158\/1078-0432.CCR-03-0392","journal-title":"Clin Cancer Res"},{"issue":"4","key":"895_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2016.26","volume":"12","author":"G Huberfeld","year":"2016","unstructured":"Huberfeld G, Vecht CJ (2016) Seizures and gliomas-towards a single therapeutic approach. Nat Rev Neurol 12(4):204\u2013216. https:\/\/doi.org\/10.1038\/nrneurol.2016.26","journal-title":"Nat Rev Neurol"},{"issue":"17","key":"895_CR25","first-page":"4383","volume":"59","author":"ZC Ye","year":"1999","unstructured":"Ye ZC, Sontheimer H (1999) Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 59(17):4383\u20134391","journal-title":"Cancer Res"},{"issue":"16","key":"895_CR26","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1007\/s00018-007-7079-x","volume":"64","author":"G Rosenberg","year":"2007","unstructured":"Rosenberg G (2007) The mechanisms of action of valproate in neuropsychiatric disorders: Can we see the forest for the trees? Cell Mol Life Sci 64(16):2090\u20132103. https:\/\/doi.org\/10.1007\/s00018-007-7079-x","journal-title":"Cell Mol Life Sci"},{"key":"895_CR27","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.2174\/138161207782360528","volume":"13","author":"M Michaelis","year":"2007","unstructured":"Michaelis M, Doerr H, Cinatl J (2007) Valproic acid as anti-cancer drug. Curr Pharm Des 13:3378\u20133393","journal-title":"Curr Pharm Des"},{"issue":"6","key":"895_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-014-0985-5","volume":"31","author":"P Bezecny","year":"2014","unstructured":"Bezecny P (2014) Histone deacetylase inhibitors in glioblastoma: Pre-clinical and clinical experience. Med Oncol 31(6):1\u201315. https:\/\/doi.org\/10.1007\/s12032-014-0985-5","journal-title":"Med Oncol"},{"issue":"1","key":"895_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/ane.12437","volume":"133","author":"HA Gefroh-Grimes","year":"2016","unstructured":"Gefroh-Grimes HA, Gidal BE (2016) Antiepileptic drugs in patients with malignant brain tumor: Beyond seizures and pharmacokinetics. Acta Neurol Scand 133(1):4\u201316. https:\/\/doi.org\/10.1111\/ane.12437","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"895_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/neuonc\/4.2.95","volume":"4","author":"H Kamitani","year":"2002","unstructured":"Kamitani H, Taniura S, Watanabe K et al (2002) Histone acetylation may suppress human glioma cell proliferation when p21WAF\/Cip1 and gelsolin are induced. Neuro-Oncology 4(2):95\u2013101. https:\/\/doi.org\/10.1093\/neuonc\/4.2.95","journal-title":"Neuro-Oncology"},{"issue":"2","key":"895_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11060-007-9402-7","volume":"85","author":"CM Das","year":"2007","unstructured":"Das CM, Aguilera D, Vasquez H et al (2007) Valproic acid induces p21 and topoisomerase-II (\u03b1\/\u03b2) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines. J Neuro-Oncol 85(2):159\u2013170. https:\/\/doi.org\/10.1007\/s11060-007-9402-7","journal-title":"J Neuro-Oncol"},{"issue":"4","key":"895_CR32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/neuonc\/nop005","volume":"12","author":"J Fu","year":"2010","unstructured":"Fu J, Shao C, Chen F et al (2010) Autophagy induced by valproic acid is associated with oxidative stress. Neuro-Oncology 12(4):328\u2013340. https:\/\/doi.org\/10.1093\/neuonc\/nop005","journal-title":"Neuro-Oncology"},{"issue":"3","key":"895_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00109-010-0707-1","volume":"89","author":"C Chen","year":"2011","unstructured":"Chen C, Chang Y, Ku MSB (2011) Enhancement of temozolomide-induced apoptosis by valproic acid in human glioma cell lines through redox regulation. J Mol Med 89(3):303\u2013315. https:\/\/doi.org\/10.1007\/s00109-010-0707-1","journal-title":"J Mol Med"},{"issue":"4","key":"895_CR34","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1158\/1535-7163.MCT-08-1076","volume":"8","author":"MSQ Kortenhorst","year":"2009","unstructured":"Kortenhorst MSQ, Isharwal S, van Diest PJ et al (2009) Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo. Mol Cancer Ther 8(4):802\u2013808. https:\/\/doi.org\/10.1158\/1535-7163.MCT-08-1076","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"895_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11060-011-0725-z","volume":"107","author":"KA Nifterik van","year":"2012","unstructured":"van Nifterik KA, van den Berg J (2012) Valproic acid sensitizes human glioma cells for temozolomide and c -radiation. J Neuro-Oncol 107(1):61\u201367. https:\/\/doi.org\/10.1007\/s11060-011-0725-z","journal-title":"J Neuro-Oncol"},{"issue":"4","key":"895_CR36","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.neuroscience.2008.07.065","volume":"156","author":"JA Ben\u00edtez","year":"2008","unstructured":"Ben\u00edtez JA, Arregui L, Cabrera G (2008) VALPROIC acid induces polarization, neuronal-like Differentiation of a subpopulation of C6 glioma cells and selectively regulates transgene expression. Neuroscience 156(4):911\u2013920. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.07.065","journal-title":"Neuroscience"},{"issue":"12","key":"895_CR37","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1007\/s11064-011-0554-7","volume":"36","author":"S Choudhury","year":"2011","unstructured":"Choudhury S, Karmakar S, Banik N, Ray S (2011) Valproic acid induced Differentiation and potentiated efficacy of Taxol and Nanotaxol for controlling growth of human. Neurochem Res 36(12):2292\u20132305. https:\/\/doi.org\/10.1007\/s11064-011-0554-7","journal-title":"Neurochem Res"},{"issue":"1","key":"895_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11060-012-0871-y","volume":"109","author":"Y Chen","year":"2012","unstructured":"Chen Y, Tsai Y, Tseng S (2012) Valproic acid affected the survival and invasiveness of human glioma cells through diverse mechanisms. J Neuro-Oncol 109(1):23\u201333. https:\/\/doi.org\/10.1007\/s11060-012-0871-y","journal-title":"J Neuro-Oncol"},{"issue":"4","key":"895_CR39","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2176\/nmc.52.186","volume":"52","author":"S Osuka","year":"2012","unstructured":"Osuka S, Takano S, Watanabe S et al (2012) Valproic acid inhibits angiogenesis in vitro and glioma angiogenesis in vivo in the brain. Neurol Med Chir (Tokyo) 52(4):186\u2013193. https:\/\/doi.org\/10.2176\/nmc.52.186","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"895_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2014.412","volume":"5","author":"M Cornago","year":"2014","unstructured":"Cornago M, Garcia-Alberich C, Blasco-Angulo N et al (2014) Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe. Cell Death Dis 5:1\u201313","journal-title":"Cell Death Dis"},{"key":"895_CR41","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1212\/WNL.0b013e31822f02e1","volume":"77","author":"M Weller","year":"2011","unstructured":"Weller M, Gorlia T, Cairncross J et al (2011) Prolonged survival with valproic acid use in the EORTC\/NCIC temozolomide trial for glioblastoma. Neurology 77:1156\u20131164","journal-title":"Neurology"},{"issue":"1053","key":"895_CR42","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20150354","volume":"88","author":"C Neubeck Von","year":"2015","unstructured":"Von Neubeck C, Seidlitz A, Kitzler HH et al (2015) Glioblastoma multiforme: Emerging treatments and stratification markers beyond new drugs. Br J Radiol 88(1053):20150354. https:\/\/doi.org\/10.1259\/bjr.20150354","journal-title":"Br J Radiol"},{"issue":"5","key":"895_CR43","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ijrobp.2015.04.038","volume":"92","author":"AV Krauze","year":"2015","unstructured":"Krauze AV, Myrehaug SD, Chang MG, Holdford DJ, Smith S, Shih J, Tofilon PJ, Fine HA et al (2015) A phase 2 study of concurrent radiation therapy, Temozolomide, and the histone deacetylase inhibitor Valproic acid for patients with glioblastoma. Int J Radiat Oncol 92(5):986\u2013992. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.04.038","journal-title":"Int J Radiat Oncol"},{"issue":"10","key":"895_CR44","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.seizure.2014.06.015","volume":"23","author":"Y Yuan","year":"2014","unstructured":"Yuan Y, Xiang W, Qing M et al (2014) Survival analysis for valproic acid use in adult glioblastoma multiforme: A meta-analysis of individual patient data and a systematic review. Seizure 23(10):830\u2013835. https:\/\/doi.org\/10.1016\/j.seizure.2014.06.015","journal-title":"Seizure"},{"issue":"5","key":"895_CR45","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1172\/JCI992","volume":"101","author":"C Wahl","year":"1998","unstructured":"Wahl C, Liptay S, Adler G, Schmid RM (1998) Sulfasalazine: A potent and specific inhibitor of nuclear factor \u03baB. J Clin Invest 101(5):1163\u20131174. https:\/\/doi.org\/10.1172\/JCI992","journal-title":"J Clin Invest"},{"issue":"1","key":"895_CR46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1124\/jpet.102.042606","volume":"305","author":"BR Ryu","year":"2003","unstructured":"Ryu BR, Lee YA, Won SJ, Noh JH, Chang SY, Chung JM, Choi JS, Joo CK et al (2003) The novel neuroprotective action of sulfasalazine through blockade of NMDA receptors. J Pharmacol Exp Ther 305(1):48\u201356. https:\/\/doi.org\/10.1124\/jpet.102.042606","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"895_CR47","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1365-2710.2005.00671.x","volume":"30","author":"G Peterson","year":"2005","unstructured":"Peterson G, Nauton M (2005) Valproate\u00a0: A simple chemical with so much to offer. J Clin Pharm Ther 30(5):417\u2013421. https:\/\/doi.org\/10.1111\/j.1365-2710.2005.00671.x","journal-title":"J Clin Pharm Ther"},{"issue":"11","key":"895_CR48","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","volume":"32","author":"D Chuang","year":"2009","unstructured":"Chuang D, Leng Y, Marinova Z et al (2009) Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci 32(11):591\u2013601. https:\/\/doi.org\/10.1016\/j.tins.2009.06.002","journal-title":"Trends Neurosci"},{"issue":"1","key":"895_CR49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1196\/annals.1344.018","volume":"1053","author":"D-M Chuang","year":"2005","unstructured":"Chuang D-M (2005) The Antiapoptotic actions of mood stabilizers. Ann N Y Acad Sci 1053(1):195\u2013204. https:\/\/doi.org\/10.1111\/j.1749-6632.2005.tb00026.x","journal-title":"Ann N Y Acad Sci"},{"issue":"9-10","key":"895_CR50","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.1432-0436.2006.00090.x","volume":"74","author":"J Faria","year":"2006","unstructured":"Faria J, Rom\u00e3o L, Martins S et al (2006) Interactive properties of human glioblastoma cells with brain neurons in culture and neuronal modulation of glial laminin organization. Differentiation 74(9-10):562\u2013572. https:\/\/doi.org\/10.1111\/j.1432-0436.2006.00090.x","journal-title":"Differentiation"},{"issue":"1","key":"895_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0736-5748(98)00002-1","volume":"16","author":"FRS Lima","year":"1998","unstructured":"Lima FRS, Gon\u00e7alves N, Gomes FC et al (1998) Thyroid hormone action on astroglial cells from distinct brain regions during development. Int J Dev Neurosci 16(1):19\u201327. https:\/\/doi.org\/10.1016\/S0736-5748(98)00002-1","journal-title":"Int J Dev Neurosci"},{"issue":"2","key":"895_CR52","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0006-8993(02)03682-X","volume":"958","author":"MS Freitas de","year":"2002","unstructured":"de Freitas MS, Spohr TCLS, Benedito AB, Caetano MS, Margulis B, Lopes UG, Moura-Neto V (2002) Neurite outgrowth is impaired on HSP70-positive astrocytes through a mechanism that requires NF-\u03baB activation. Brain Res 958(2):359\u2013370. https:\/\/doi.org\/10.1016\/S0006-8993(02)03682-X","journal-title":"Brain Res"},{"key":"895_CR53","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.brainres.2010.07.071","volume":"1355","author":"SO Loureiro","year":"2010","unstructured":"Loureiro SO, Rom\u00e3o L, Alves T, Fonseca A, Heimfarth L, Neto VM, Wyse ATS, Pessoa-Pureur R (2010) Homocysteine induces cytoskeletal remodeling and production of reactive oxygen species in cultured cortical astrocytes. Brain Res 1355:151\u2013164. https:\/\/doi.org\/10.1016\/j.brainres.2010.07.071","journal-title":"Brain Res"},{"issue":"49","key":"895_CR54","doi-asserted-by":"publisher","first-page":"41432","DOI":"10.1074\/jbc.M112.380824","volume":"287","author":"LP Diniz","year":"2012","unstructured":"Diniz LP, Almeida JC, Tortelli V, Vargas Lopes C, Setti-Perdig\u00e3o P, Stipursky J, Kahn SA, Rom\u00e3o LF et al (2012) Astrocyte-induced synaptogenesis is mediated by transforming growth factor \u03b2 signaling through modulation of d-serine levels in cerebral cortex neurons. J Biol Chem 287(49):41432\u201341445. https:\/\/doi.org\/10.1074\/jbc.M112.380824","journal-title":"J Biol Chem"},{"issue":"10","key":"895_CR55","doi-asserted-by":"publisher","first-page":"13743","DOI":"10.1007\/s13277-016-5255-z","volume":"37","author":"AO Silva","year":"2016","unstructured":"Silva AO, Felipe KB, Villodre ES, Lopez PLC, Lenz G (2016) A guide for the analysis of long-term population growth in cancer. Tumor Biol 37(10):13743\u201313749. https:\/\/doi.org\/10.1007\/s13277-016-5255-z","journal-title":"Tumor Biol"},{"key":"895_CR56","doi-asserted-by":"publisher","unstructured":"Villodre ES, Kipper FC, Silva AO, et al (2017) Low Dose of Doxorubicin Potentiates the Effect of Temozolomide in Glioblastoma Cells. https:\/\/doi.org\/10.1007\/s12035-017-0611-6","DOI":"10.1007\/s12035-017-0611-6"},{"key":"895_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0042522","volume":"7","author":"EC Filippi-Chiela","year":"2012","unstructured":"Filippi-Chiela EC, Oliveira MM, Jurkovski B et al (2012) Nuclear morphometric analysis (NMA): Screening of senescence, apoptosis and nuclear irregularities. PLoS One 7:1\u201310","journal-title":"PLoS One"},{"key":"895_CR58","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.exer.2015.11.027","volume":"146","author":"R Carpi-Santos","year":"2016","unstructured":"Carpi-Santos R, Ferreira MJ, Netto ADP et al (2016) Early changes in system and glutathione in the retina of diabetic rats. Exp Eye Res 146:35\u201342. https:\/\/doi.org\/10.1016\/j.exer.2015.11.027","journal-title":"Exp Eye Res"},{"issue":"3","key":"895_CR59","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"T-C Chou","year":"2006","unstructured":"Chou T-C (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58(3):621\u2013681. https:\/\/doi.org\/10.1124\/pr.58.3.10","journal-title":"Pharmacol Rev"},{"issue":"13","key":"895_CR60","doi-asserted-by":"crossref","first-page":"9397","DOI":"10.1016\/S0021-9258(17)36891-6","volume":"269","author":"A Meister","year":"1994","unstructured":"Meister A (1994) Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem 269(13):9397\u20139400","journal-title":"J Biol Chem"},{"issue":"1","key":"895_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbrc.2011.05.070","volume":"410","author":"L Mardones","year":"2011","unstructured":"Mardones L, Ormazabal V, Romo X, Ja\u00f1a C, Binder P, Pe\u00f1a E, Vergara M, Z\u00fa\u00f1iga FA (2011) The glucose transporter-2 (GLUT2) is a low affinity dehydroascorbic acid transporter. Biochem Biophys Res Commun 410(1):7\u201312. https:\/\/doi.org\/10.1016\/j.bbrc.2011.05.070","journal-title":"Biochem Biophys Res Commun"},{"key":"895_CR62","doi-asserted-by":"publisher","first-page":"28246","DOI":"10.1074\/jbc.M000988200","volume":"275","author":"SC Rumsey","year":"2000","unstructured":"Rumsey SC, Daruwala R, Al-Hasani H et al (2000) Dehydroascorbic acid transport by GLUT4 in Xenopus oocytes and isolated rat adipocytes. J Biol Chem 275:28246\u201328253. https:\/\/doi.org\/10.1074\/jbc.M000988200","journal-title":"J Biol Chem"},{"issue":"30","key":"895_CR63","doi-asserted-by":"publisher","first-page":"18982","DOI":"10.1074\/jbc.272.30.18982","volume":"272","author":"SC Rumsey","year":"1997","unstructured":"Rumsey SC, Kwon O, Xu GW, Burant CF, Simpson I, Levine M (1997) Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J Biol Chem 272(30):18982\u201318989. https:\/\/doi.org\/10.1074\/jbc.272.30.18982","journal-title":"J Biol Chem"},{"issue":"3","key":"895_CR64","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0014-5793(99)01393-9","volume":"460","author":"R Daruwala","year":"1999","unstructured":"Daruwala R, Song J, Koh WS et al (1999) Cloning and functional characterization of the human sodium-dependent vitamin C transporters hSVCT1 and hSVCT2. FEBS Lett 460(3):480\u2013484. https:\/\/doi.org\/10.1016\/S0014-5793(99)01393-9","journal-title":"FEBS Lett"},{"issue":"2","key":"895_CR65","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1006\/bbrc.1999.1929","volume":"267","author":"Y Wang","year":"2000","unstructured":"Wang Y, Mackenzie B, Tsukaguchi H et al (2000) Human vitamin C (l-ascorbic acid) transporter SVCT1. Biochem Biophys Res Commun 267(2):488\u2013494. https:\/\/doi.org\/10.1006\/bbrc.1999.1929","journal-title":"Biochem Biophys Res Commun"},{"key":"895_CR66","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/19986","volume":"399","author":"H Tsukaguchi","year":"1999","unstructured":"Tsukaguchi H, Tokui T, Mackenzie B et al (1999) A family of mammalian Na+\u2212dependent L-ascorbic acid transporters. Nature 399:70\u201375","journal-title":"Nature"},{"issue":"4","key":"895_CR67","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/jnc.12663","volume":"129","author":"P Cisternas","year":"2014","unstructured":"Cisternas P, Silva-Alvarez C, Mart\u00ednez F et al (2014) The oxidized form of vitamin C, dehydroascorbic acid, regulates neuronal energy metabolism. J Neurochem 129(4):663\u2013671. https:\/\/doi.org\/10.1111\/jnc.12663","journal-title":"J Neurochem"},{"key":"895_CR68","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-94-007-2199-9_6","volume-title":"Water soluble Vitam. Clin. Res. Futur. Appl","author":"JM May","year":"2012","unstructured":"May JM (2012) Vitamin C transport and its role in the central nervous system. In: Stanger O (ed) Water soluble Vitam. Clin. Res. Futur. Appl. Springer Netherlands, Dordrecht, pp. 85\u2013103. https:\/\/doi.org\/10.1007\/978-94-007-2199-9_6"},{"issue":"6","key":"895_CR69","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.freeradbiomed.2008.12.018","volume":"46","author":"FE Harrison","year":"2009","unstructured":"Harrison FE, May JM (2009) Vitamin C function in the brain: Vital role of the ascorbate transporter SVCT2. Free Radic Biol Med 46(6):719\u2013730. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2008.12.018","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"895_CR70","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1471-4159.2008.05786.x","volume":"108","author":"CC Portugal","year":"2009","unstructured":"Portugal CC, Miya VS, Calaza K da C et al (2009) Glutamate receptors modulate sodium-dependent and calcium-independent vitamin C bidirectional transport in cultured avian retinal cells. J Neurochem 108(2):507\u2013520. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05786.x","journal-title":"J Neurochem"},{"issue":"6","key":"895_CR71","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1074\/jbc.M111.260166","volume":"287","author":"CC Portugal","year":"2012","unstructured":"Portugal CC, da Encarna\u00e7\u00e3o TG, Socodato R et al (2012) Nitric oxide modulates sodium vitamin C transporter 2 (SVCT-2) protein expression via protein kinase G (PKG) and nuclear factor-\u03baB (NF-\u03baB). J Biol Chem 287(6):3860\u20133872. https:\/\/doi.org\/10.1074\/jbc.M111.260166","journal-title":"J Biol Chem"},{"issue":"2","key":"895_CR72","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0920-1211(99)00005-4","volume":"35","author":"V Venkataraman","year":"2016","unstructured":"Venkataraman V, Wheless JW (2016) Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients. Epilepsy Res 35(2):147\u2013153. https:\/\/doi.org\/10.1016\/S0920-1211(99)00005-4","journal-title":"Epilepsy Res"},{"issue":"5","key":"895_CR73","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1049\/iet-ipr.2014.0531","volume":"9","author":"R Ziraldo","year":"2015","unstructured":"Ziraldo R, Link N, Abrams J, Ma L (2015) Towards automatic image analysis and assessment of the multicellular apoptosis process. IET image Process\/IET 9(5):424\u2013433. https:\/\/doi.org\/10.1049\/iet-ipr.2014.0531","journal-title":"IET image Process\/IET"},{"issue":"1","key":"895_CR74","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12031-014-0241-7","volume":"54","author":"FA Sassi de","year":"2014","unstructured":"de Sassi FA, Caesar L, Jaeger M et al (2014) Inhibitory activities of Trichostatin a in U87 glioblastoma cells and Tumorsphere-derived cells. J Mol Neurosci 54(1):27\u201340. https:\/\/doi.org\/10.1007\/s12031-014-0241-7","journal-title":"J Mol Neurosci"},{"key":"895_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2015.11.002","volume":"24","author":"TV Denisenko","year":"2016","unstructured":"Denisenko TV, Sorokina IV, Gogvadze V, Zhivotovsky B (2016) Mitotic catastrophe and cancer drug resistance: A link that must to be broken. Drug Resist Updat 24:1\u201312. https:\/\/doi.org\/10.1016\/j.drup.2015.11.002","journal-title":"Drug Resist Updat"},{"key":"895_CR76","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/cdd.2011.96","volume":"19","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Vitale I, Abrams JM et al (2012) Molecular definitions of cell death subroutines: Recommendations of the nomenclature committee on cell death 2012. Cell Death Differ 19:107\u2013120","journal-title":"Cell Death Differ"},{"issue":"6","key":"895_CR77","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrm3115","volume":"12","author":"I Vitale","year":"2011","unstructured":"Vitale I, Galluzzi L, Castedo M, Kroemer G (2011) Mitotic catastrophe: A mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol 12(6):385\u2013392. https:\/\/doi.org\/10.1038\/nrm3115","journal-title":"Nat Rev Mol Cell Biol"},{"key":"895_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/146282","volume":"2015","author":"MM McGee","year":"2015","unstructured":"McGee MM (2015) Targeting the mitotic catastrophe signaling pathway in cancer. Mediat Inflamm 2015:1\u201313. https:\/\/doi.org\/10.1155\/2015\/146282","journal-title":"Mediat Inflamm"},{"key":"895_CR79","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/cdd.2008.47","volume":"15","author":"H Vakifahmetoglu","year":"2008","unstructured":"Vakifahmetoglu H, Olsson M, Zhivotovsky B (2008) Death through a tragedy: Mitotic catastrophe. Cell Death Differ 15:1153\u20131162","journal-title":"Cell Death Differ"},{"issue":"19","key":"895_CR80","doi-asserted-by":"publisher","first-page":"7751","DOI":"10.1073\/pnas.0903139106","volume":"106","author":"M Haberland","year":"2009","unstructured":"Haberland M, Johnson A, Mokalled MH et al (2009) Genetic dissection of histone deacetylase requirement in tumor cells. Proc Natl Acad Sci 106(19):7751\u20137755. https:\/\/doi.org\/10.1073\/pnas.0903139106","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"895_CR81","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.3892\/ol.2016.4113","volume":"11","author":"Y Iwadate","year":"2016","unstructured":"Iwadate Y (2016) Epithelial-mesenchymal transition in glioblastoma progression. Oncol Lett 11(3):1615\u20131620. https:\/\/doi.org\/10.3892\/ol.2016.4113","journal-title":"Oncol Lett"},{"issue":"1","key":"895_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3591-z","volume":"17","author":"M-G Noh","year":"2017","unstructured":"Noh M-G, Oh S-J, Ahn E-J, Kim YJ, Jung TY, Jung S, Kim KK, Lee JH et al (2017) Prognostic significance of E-cadherin and N-cadherin expression in gliomas. BMC Cancer 17(1):583. https:\/\/doi.org\/10.1186\/s12885-017-3591-z","journal-title":"BMC Cancer"},{"issue":"05","key":"895_CR83","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4172\/2157-7633.1000209","volume":"4","author":"F Nualart","year":"2014","unstructured":"Nualart F, Mack L, Garc\u00eda A et al (2014) Vitamin C transporters, recycling and the bystander effect in the nervous system: SVCT2 versus Gluts. J Stem Cell Res Ther 4(05):209. https:\/\/doi.org\/10.4172\/2157-7633.1000209","journal-title":"J Stem Cell Res Ther"},{"issue":"894","key":"895_CR84","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/448645a","volume":"448","author":"C Chong","year":"2007","unstructured":"Chong C, Sullivan D (2007) New uses for old drugs. Nature 448(894):645\u2013646. https:\/\/doi.org\/10.2165\/00128413-199308940-00046","journal-title":"Nature"},{"issue":"7","key":"895_CR85","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S1590-8658(01)80108-0","volume":"33","author":"MC Paolo di","year":"2001","unstructured":"di Paolo MC, Paoluzi OA, Pica R et al (2001) Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: Report on tolerance and side-effects. Dig Liver Dis 33(7):563\u2013569. https:\/\/doi.org\/10.1016\/S1590-8658(01)80108-0","journal-title":"Dig Liver Dis"},{"issue":"3","key":"895_CR86","first-page":"79","volume":"22","author":"AV Sood","year":"2003","unstructured":"Sood AV, Midha N, Sood GA (2003) Azathioprine versus sulfasalazine in maintance of remission in severe ulcerative colitis. Indian J Gastroenterol 22(3):79\u201381","journal-title":"Indian J Gastroenterol"},{"issue":"11","key":"895_CR87","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJM199209103271104","volume":"327","author":"RH Mattson","year":"1992","unstructured":"Mattson RH, Cramer JA, Collinds JF (1992) A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic\u2013Clonic seizures in adults. N Engl J Med 327(11):765\u2013771. https:\/\/doi.org\/10.1056\/NEJM199209103271104","journal-title":"N Engl J Med"},{"issue":"1","key":"895_CR88","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s40263-015-0304-5","volume":"30","author":"AM Cook","year":"2016","unstructured":"Cook AM, Zafar MS, Mathias S, Stewart AM, Albuja AC, Bensalem-Owen M, Kapoor S, Baumann RJ (2016) Pharmacokinetics and clinical utility of Valproic acid administered via continuous infusion. CNS Drugs 30(1):71\u201377. https:\/\/doi.org\/10.1007\/s40263-015-0304-5","journal-title":"CNS Drugs"},{"issue":"7","key":"895_CR89","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1200\/JCO.2015.63.6563","volume":"34","author":"C Happold","year":"2016","unstructured":"Happold C, Gorlia T, Chinot O et al (2016) Does Valproic acid or Levetiracetam improve survival in glioblastoma? A pooled analysis of prospective clinical trials in newly diagnosed glioblastoma. J Clin Oncol 34(7):731\u2013739. https:\/\/doi.org\/10.1200\/JCO.2015.63.6563","journal-title":"J Clin Oncol"},{"issue":"8","key":"895_CR90","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/glia.21137","volume":"59","author":"IK Mellinghoff","year":"2011","unstructured":"Mellinghoff IK, Lassman AB, Wen PY (2011) Signal transduction inhibitors and antiangiogenic therapies for malignant glioma. Glia 59(8):1205\u20131212. https:\/\/doi.org\/10.1002\/glia.21137","journal-title":"Glia"},{"issue":"1","key":"895_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10143-016-0709-8","volume":"40","author":"NAO Bush","year":"2016","unstructured":"Bush NAO, Chang SM, Berger MS (2016) Current and future strategies for treatment of glioma. Neurosurg Rev 40(1):1\u201314. https:\/\/doi.org\/10.1007\/s10143-016-0709-8","journal-title":"Neurosurg Rev"},{"issue":"8","key":"895_CR92","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1093\/neuonc\/now102","volume":"18","author":"F Bernard-Arnoux","year":"2016","unstructured":"Bernard-Arnoux F, Lamure M, Ducray F et al (2016) The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma. Neuro-Oncology 18(8):1129\u20131136. https:\/\/doi.org\/10.1093\/neuonc\/now102","journal-title":"Neuro-Oncology"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-0895-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-0895-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-0895-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T21:39:11Z","timestamp":1660340351000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-0895-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,19]]},"references-count":92,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["895"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-0895-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,19]]},"assertion":[{"value":"6 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research had written informed consent from the patients and was approved by the Brazilian Ministry of Health Ethics Committee, under Institutional Review Board (IRB-Research Ethics Committee of Hospital Universit\u00e1rio Clementino Fraga Filho) consent CEP-HUCFF No. 002\/01. All patients gave written consent to the use of their surgical specimens for isolation of cortical cells (including astrocytes) in the study, and the procedures were approved by the Brazilian Ministry of Health Ethics Committee under IRB consent (CEP-HUCFF No. 060\/05).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}}]}}